Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)

Regenxbio's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $100.9 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments rose 94.73% year-over-year to $100.9 million; the TTM figure through Dec 2025 stood at $319.1 million (up 9.95% YoY), while the FY2025 annual figure was $319.1 million, up 9.95% from the prior year.
• Change in Acquisitions & Divestments was $100.9 million for Q4 2025 at Regenxbio, up from $82.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $107.6 million in Q2 2023 to a low of -$158.5 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $45.0 million across 5 years, with a median of $60.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 566125.0% in 2022, then soared 190.55% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $28000.0 in 2021, then tumbled by 566125.0% to -$158.5 million in 2022, then surged by 133.91% to $53.7 million in 2023, then retreated by 3.62% to $51.8 million in 2024, then soared by 94.73% to $100.9 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $100.9 million (Q4 2025), $82.2 million (Q3 2025), and $71.1 million (Q2 2025), per Business Quant data.